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Abstract 
Despite the available data regarding antimicrobial activity of phenolic acids, studies 
dealing with the effects of their metabolites or derivatives are scarce. Therefore, the 
antimicrobial and demelanizing activities of Coprinopsis atramentaria extract, its organic 
acids, and methylated and glucuronated derivatives were evaluated. The antifungal 
activity was stronger than the antibacterial effects. In general, individual compounds 
(mostly organic acids) gave higher activity than the extract and even higher than the 
standards used in the assays. Methylated derivatives presented the highest demelanizing 
activity toward Aspergillus niger, A. fumigatus and Penicillium verrucosum var. 
cyclopium). The inclusion of methyl groups in the parental compound (CoAM1, CoAM2 
and CoAM3) strongly increased antibacterial and antifungal activities of CoA, while the 
inclusion of acetyl groups (CoAGP) increased the antifungal activity but the antibacterial 
properties were maintained. For HA and CA, the inclusion of methyl groups (HAM1, 
HAM2, HAM3 and CAM) increased the demelanizing activity, but decreased the 
antimicrobial properties. The present work contributes to the knowledge of the 
mechanisms involved in the antimicrobial properties of organic acids namely, phenolic 
acids, usually present in mushrooms. Organic acids, methylated and glucuronated 
derivatives could be used as antimicrobial agents. 
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Introduction 
Global antibacterial resistance is an increasing public health problem due to the bacterial 
resistance developed to almost all the antibiotics.1 Natural resources have been exploited 
in the last years and among them, mushrooms could be an alternative source of new 
antimicrobials.2  
Although fungi are well known for the production of important antibiotic compounds 
(penicillins, streptomycins, rifamycins and others), the occurrence of antibiotics in 
mushrooms is less well documented.1 Nevertheless, the scientific community, searching 
for new therapeutic alternatives, studied many different species of mushrooms and has 
found antimicrobial effects.2-5  
 Lentinus edodes is the most studied species regarding antimicrobial properties and seems 
to have a broad activity against both gram-positive and gram-negative bacteria,2 and 
fungi.6 Nonetheless, the antimicrobial activity of wild species (mostly methanolic 
extracts) has also been reported, such as Lactarius deliciosus,7 Lepista nuda,8 Morchella 
esculenta4 and Ganoderma lucidum.5  
Coprinopsis atramentaria (Bull.: Fr.) Redhead, Vilgalys & Moncalvo, is a wild edible 
mushroom previously characterized by us for its nutritional composition, and its 
methanolic extract showed antioxidant9  and antitumor activities.10 p-Hydroxybenzoic 
(4.71 mg/100 g dry weight), p-coumaric (0.82  mg/100 g) and cinnamic (1.70 mg/100 g) 
acids were identified in the mentioned extract. Nonetheless, the mentioned compounds 
are rapidly metabolized in the human organism. Glucuronidation and methylation appears 
as prevalent metabolic pathways for phenolic acids in humans.11  
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So, despite dietary phenolic compounds being widely considered to contribute to health 
benefits in humans, little is known about the bioactive forms in vivo and the mechanisms 
by which they may contribute toward disease prevention. In fact, despite the available 
data concerning antimicrobial effects of phenolic acids,12-14 studies dealing with the 
antimicrobial activity of their metabolites or derivatives are scarce. 
In the present work, it was evaluated and compared the antimicrobial and demelanizing 
activity of: i) C. atramentaria extract; ii) compounds identified in the extract: p-
hydroxybenzoic, p-coumaric and cinnamic acids; iii) acetylated glucuronide derivatives 
(protected glucuronides) and iv) methylated derivatives, both prepared by chemical 
synthesis. 
 
Experimental 
Wild mushroom 
Samples of Coprinopsis atramentaria (Bull.: Fr.) Redhead, Vilgalys & Moncalvo were 
collected in Bragança (Northeast Portugal). After taxonomic identification of the 
sporocarps,15 specimens were deposited at the herbarium of Escola Superior Agrária of 
Instituto Politécnico de Bragança. The samples were lyophilized (FreeZone 4.5 model 
7750031, Labconco, Kansas, USA) and reduced to a fine dried powder (20 mesh). 
 
Preparation of the extract 
The powder (∼10 g) was extracted with methanol (250 mL) at -20 °C for 6 h. The extract 
was sonificated for 15 min, centrifuged at 4000g for 10 min and filtered through 
Whatman No.4 paper. The residue was then re-extracted with three additional 150 mL 
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portions of methanol. The combined extracts were evaporated (rotary evaporator Büchi 
R-210; Flawil, Switzerland) at 40 °C to dryness. 
 
Compounds tested 
p-Hydroxybenzoic, p-coumaric and cinnamic acids (related to phenolic acids) were 
identified in C. atramentaria extract.9 For the antimicrobial assays, these compounds 
(Figure 1) were purchased from Sigma (St. Louis, MO, USA).  
Methylated and glucuronated derivatives (Figure 1) were synthesized and completely 
characterized as described previously by the authors,10 and used in the antimicrobial 
assays.  
 
Antibacterial activity 
The following Gram-negative bacteria: Escherichia coli (ATCC 35210), Pseudomonas 
aeruginosa (ATCC 27853), Salmonella typhimurium (ATCC 13311), Enterobacter 
cloacae (ATCC 35030), and Gram-positive bacteria: Staphylococcus aureus (ATCC 
6538), Bacillus cereus (clinical isolate), Micrococcus flavus (ATCC 10240), and Listeria 
monocytogenes (NCTC 7973) were used. The microorganisms were obtained from the 
Mycological laboratory, Department of Plant Physiology, Institute for biological research 
“Siniša Stanković”, University of Belgrade, Serbia.  
The minimum inhibitory (MIC) and minimum bactericidal (MBC) concentrations were 
determined by the microdilution method. Briefly, fresh overnight culture of bacteria was 
adjusted by the spectrophotometer to a concentration of 1×105 CFU/mL. The requested 
CFU/mL corresponded to a bacterial suspension determined in a spectrophotometer at 
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625 nm (OD 625). Dilutions of inocula were cultured on solid medium to verify the 
absence of contamination and check the validity of the inoculum. Extract and compounds 
tested were carried out in different dilution over the wells containing 100 µL of Tryptic 
Soy Broth (TSB) and afterwards, 10 µL of inoculum was added to all the wells. The 
microplates were incubated for 24h at 37°C. The MIC of the samples was detected 
following the addition of 40 µL of iodonitrotetrazolium chloride (INT) (0.2 mg/mL) and 
incubation at 37°C for 30 min. The lowest concentration that produced a significant 
inhibition (around 50%) of the growth of the bacteria in comparison with the positive 
control was identified as the MIC. The minimum inhibitory concentrations (MICs) 
obtained from the susceptibility testing of various bacteria to tested extract were 
determined also by a colorimetric microbial viability assay based on reduction of a INT 
color and compared with positive control for each bacterial strains.16,17 MBC was 
determined by serial sub-cultivation of 10 µL into microplates containing 100 µL of TSB. 
The lowest concentration that shows no growth after this sub-culturing was read as the 
MBC. Standard drugs, namely streptomycin and ampicillin were used as positive 
controls. 5% DMSO was used as negative control. 
 
Antifungal activity  
 For the antifungal bioassays, the following microfungi were used: Aspergillus fumigatus 
(ATCC 1022), Aspergillus ochraceus (ATCC 12066), Aspergillus versicolor (ATCC 
11730), Aspergillus niger (ATCC 6275), Trichoderma viride (IAM 5061), Penicillium 
funiculosum (ATCC 36839), Penicillium ochrochloron (ATCC 9112) and Penicillium 
verrucosum var. cyclopium (food isolate). The organisms were obtained from the 
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Mycological Laboratory, Department of Plant Physiology, Institute for Biological 
Research “Siniša Stanković”, Belgrade, Serbia.	 The micromycetes were maintained on 
malt agar (MA) and the cultures were stored at 4°C and sub-cultured once a month.18  
The fungal spores were washed from the surface of agar plates with sterile 0.85% saline 
containing 0.1% Tween 80 (v/v). The spore suspension was adjusted with sterile saline to 
a concentration of approximately 1.0×105 in a final volume of 100 µL/well. The inocula 
were stored at 4°C for further use. Dilutions of the inocula were cultured on solid MA to 
verify the absence of contamination and to check the validity of the inoculum. 
Minimum inhibitory concentrations (MICs) determination was performed by a serial 
dilution technique using 96-well microtitre plates. The investigated extract and 
compounds were dissolved in 5% solution of DMSO and added to broth malt medium 
with fungal inoculum. The microplates were incubated for 72h at 28°C. The lowest 
concentrations without visible growth (at the binocular microscope) were defined as 
MIC. The minimum fungicidal concentrations (MFCs) were determined by serial 
subcultivation of 2 µL in microtitre plates containing 100 µL of malt broth per well and 
further incubation for 72h at 28°C. The lowest concentration with no visible growth was 
defined as the MFC, indicating 99.5% killing of the original inoculum.19 DMSO 5 % was 
used as a negative control, while bifonazole and ketoconazole were used as positive 
controls. 
 
Demelanizing activity using micromycetes 
 All the microfungi tested for antifungal activity of C. atramentaria methanolic extract 
and compounds were used to evaluate extract/compounds demelanizing activity. The 
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micromycetes were maintained on malt agar and the cultures were stored at 4°C; 96-well 
microliter plates were used. The fungal spores were washed from the surface of agar 
plates with sterile 0.85% saline containing 0.1% Tween 80 (v/v). The spore suspension 
was adjusted with sterile saline to a proximate concentration of 1.0x105 in a final volume 
of 100 µL/well. Dilutions of the inocula were cultured on malt agar to verify the absence 
of contamination and to check the validity of the inoculum. Determination of minimum 
demelanizing concentrations (MDC) was performed by a serial dilution technique. The 
extract/compounds were dissolved in 5% DMSO solution containing 0.1% Tween 80 
(v/v) (10 mg/mL) and added in broth Malt medium with inoculum. The microplates were 
incubated at Rotary shaker (160 rpm) for 72 h at 28° C. A sample of mycelium was taken 
from the periphery of a colony grown on Malt extract medium enriched with different 
concentrations of tested extract. The samples were dried and fixed with lactophenol and 
observed under a light microscope (Microscope DMLS Typ 020 518 500. Leica, Wetzlar. 
Neubauer Zählkammer. Eppendorf, Hamburg, Germany) to examine structural 
abnormalities.5 The lowest concentration that provoked demelanization of fungal hyphae 
and conidia was determined as MDC. Samples from the control plate without added 
extracts were also stained and observed. Solution of 5% DMSO was used as a negative 
control.  
 
Results 
Antibacterial activity 
The methanolic extract of C. atramentaria was active against all the tested bacteria with 
minimal inhibitory concentrations (MICs) of 1.0-2.0 mg/mL and bactericidal 
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concentrations (MBCs) of 2.0-4.0 mg/mL (Table 1). The most resistant bacteria to the 
extract were Micrococcus flavus and Pseudomonas aeruginosa. 
 p-Coumaric acid (CoA) showed activity against all the tested bacteria presenting MICs 
of 0.047-0.140 mg/mL and MBCs of 0.094-0.180 mg/mL being Bacillus cereus the most 
susceptible bacteria to this phenolic acid. CoA showed higher activity than streptomycin 
against all the bacteria except for Staphylococcus aureus and, higher activity than 
ampicillin for all the bacteria. CoAGP showed activity against all the studied bacteria 
presenting MICs of 0.047-0.140 mg/mL and MBCs of 0.094-0.375 mg/mL. The most 
susceptible bacteria to this compound was Listeria monocytogenes and the most resistant 
were S. aureus and Escherichia coli. CoAGP revealed higher activity than streptomycin 
against almost all the bacteria except for S. aureus and E. coli and, higher activity than 
ampicillin for all the bacteria studied. 
CoAM1 showed antibacterial activity with MICs of 0.020-0.125 mg/mL and MBCs of 
0.065-0.250 mg/mL, being B. cereus and L. monocytogenes the most susceptible bacteria, 
while E. coli was the most resistant. CoAM1 showed higher activity than streptomycin 
against all the bacteria except for S. aureus and, higher activity than ampicillin for all the 
bacteria. CoAM2 also revealed antibacterial activity against all the bacteria with MICs of 
0.0312-0.125 mg/mL and MBCs of 0.0625-0.250 mg/mL. The most susceptible bacteria 
to this compound were Salmonella typhimurium and Enterobacter cloacae, while the 
most resistant were E. coli and M. flavus. CoAM2 showed higher activity than the two 
standards for all the tested bacteria. CoAM3 also presented activity for all the studied 
bacteria with MICs of 0.0312-0.250 mg/mL and MBCs of 0.0625-0.500 mg/mL. The 
most susceptible bacteria were S. aureus, B. cereus and E. cloacae, being P. aeruginosa 
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and E. coli the most resistant ones. CoAM3 had higher activity than streptomycin against 
all bacteria, except P. aeruginosa and E. coli, and higher activity than ampicillin against 
all the bacteria.  
Methylated derivatives of p-coumaric acid (CoAM1, CoAM2 and CoAM3) revealed 
higher activity than the parental compound (p-coumaric acid), while for the glucuronide 
derivative (CoAGP), the antibacterial activity was maintained for almost all the bacteria. 
HAM1 and HAM2 presented almost the same activity with MICs of 0.0625-0.200 
mg/mL and MBCs of 0.125-0.250 mg/mL, being L. monocytogenes the most susceptible 
bacteria. HAM1 and HAM2 showed higher activity than streptomycin against almost all 
the tested bacteria except for S. aureus and B. cereus, and higher activity than ampicillin 
against all the bacteria. HAM3 also had antibacterial activity with MICs of 0.047-0.070 
mg/mL and MBCs of 0.094 mg/mL. L. monocytogenes, P. aeruginosa, S. typhimurium 
and E. cloacae were the most susceptible bacteria to this compound. HAM3 revealed 
higher activity than the two standards against all the tested bacteria. 
Methylated derivatives (HAM1, HAM2 and HAM3) presented lower antibacterial 
activity than the parental compound HA, but in most cases higher than the two studied 
standards. 
CAM was active against all the tested bacteria with MICs of 0.0625-0.250 mg/mL and 
MBCs of 0.125-0.500 mg/mL. L. monocytogenes, P. aeruginosa and E. cloacae were the 
most susceptible bacteria while M. flavus was the most resistant one. CAM revealed 
higher activity than streptomycin against almost all the bacteria except for S. aureus, B. 
cereus and M. flavus, and also higher activity than ampicillin for all the bacteria except 
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for M. flavus. CA presented an excellent antibacterial activity against all the bacteria, and 
higher than its derivative, CAM, and much higher than the two standards.  
All the compounds presented higher activity than C. atramentaria extract. 
 
Antifungal activity 
C. atramentaria methanolic extract revealed antifungal activity and all the tested 
compounds showed very high antifungal potential when compared with antifungal 
standards bifonazole and ketoconazole (Table 2). The extract presented MICs of 0.5-2.0 
mg/mL and minimum fungicidal concentrations (MFCs) of 1.0-4.0 mg/mL. The highest 
activity was verified for Penicillium ochrochloron, while Aspergillus fumigatus was the 
most resistant fungi.  
CoA was active against all the tested fungi with MICs of 0.0625-0.250 mg/mL and MFCs 
of 0.125-0.450 mg/mL, being A. versicolor the most susceptible fungi while A. niger and 
P. funiculosum were the most resistant ones. CoA showed higher activity than bifonazole 
against A. versicolor, and than ketoconazole against the majority of the fungi. CoAGP 
showed a moderate activity with MICs of 0.014-0.056 mg/mL and MFCs of 0.125-0.250 
mg/mL. A. ochraceus, P. ochrochloron and P. verrucosum were the most susceptible 
fungi, while A. versicolor and A. niger were the most resistant fungi. CoAGP showed 
higher activity than ketoconazole against all the fungi and higher than befonazole against 
A. versicolor, P. ochrochloron and P. verrucosum. 
 CoAM1 showed antifungal activity presenting MICs of 0.015-0.150 mg/mL and MFCs 
of 0.0625-0.625 mg/mL, being A. versicolor and P. ochrochloron the most susceptible 
fungi, while A. fumigatus was the most resistant one. This compound showed higher 
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activity than the two standards against the majority of the tested fungi.  CoAM2 showed 
an excellent activity presenting MICs of 0.0078-0.047 mg/mL and MFCs of 0.015-0.0625 
mg/mL; all the tested fungi were very susceptible to this compound with the exception of 
A. ochraceus and A. niger that were the most resistant ones. CoAM2 showed much higher 
antifungal activity than the two standards tested. CoAM3 presented MICs of 0.0078-
0.120 mg/mL and MFCs of 0.015-0.450 mg/mL, showing the best activity against A. 
versicolor and the lowest against A. niger. CoAM3 presented higher activity than the two 
standards against the majority of the fungi. All the p-coumaric acid derivatives, 
methylated (CoAM1, CoAM2 and CoAM3) and glucuronated (CoAGP) showed higher 
activity than the parental compound and in the most of the cases higher antifungal 
activity than the standards, particularly CoAM2 that presented an excellent activity.  
HAM1 was active against all the tested fungi with MICs of 0.015-0.0625 mg/mL and 
MFCs of 0.0312-0.125 mg/mL, being Tricholoma viride and P. funiculosum the most 
susceptible fungi, while A. niger was the most resistant fungi. HAM1 showed a much 
higher activity than the two standards against all the fungi. HAM2 was active with MICs 
of 0.0125-0.0625 mg/mL and MFCs of 0.0625-0.125 mg/mL. The best activity was 
against T. viride, P. funiculosum and P. ochrochloron and the lowest activity was against 
A. niger. HAM2 showed higher activity than the two standards against all the tested 
fungi. HAM3 presented MICs of 0.0312-0.250 mg/mL and MFCs of 0.125-0.450 mg/mL, 
being P. funiculosum and P. ochrochloron the most susceptible fungi, while T. viride was 
the most resistant one. This compound showed higher antifungal activity than the two 
standards against the majority of the tested fungi. All HA methylated derivatives showed 
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higher activity than the two standards against all the tested fungi, but lowest activity than 
the parental compound.   
CAM revealed a good activity against all the fungi with MICs of 0.015-0.047 mg/mL and 
MFCs of 0.0312-0.0625 mg/mL. A. versicolor, P. funiculosum and P. ochrochloron were 
the most susceptible fungi, while A. niger was the most resistant. CAM showed much 
higher antifungal activity than the two standards against all the fungi, but lower activity 
than the correspondent parental organic acid. All the compounds revealed antifungal 
activity in a range of MICs 0.0078-0.250 mg/mL and MFCs 0.0150-0.450 mg/mL.  
All the tested compounds presented higher antifungal activity than the C. atramentaria 
extract. 
 
Demelanizing activity  
Demelanizing activity of extract and individual compounds was evaluated toward the 
eight microfungi also used in antifungal activity assays; nevertheless the effects were 
significant for Aspergillus niger, A. fumigatus and Penicillium verrucosum var. 
cyclopium. 
The extract and organic acid derivatives showed demelanizing effect on A. niger at 
concentration 0.030-0.100 mg/mL (example of HAM1 in Figure 2B; Figure 3A and 3B). 
Compounds HAM1 and HAM3 (Figure 2A; Figure 3C and D) showed demelanizing 
effect on A. fumigatus, lowering the amount of conidia and giving nude vesicle without 
conidia at concentration 0.030-0.100 mg/mL. Demelanizing activity of CoAM1, CoAM2, 
HAM3 and CAM (Figure 2C and 3E and 3F) was noticed on P. verrucosum at 
concentration of 0.005-0.05 mg/mL, provoking fialides without conidia and lower 
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numbers of conidia. Minimum demelanizing concentrations (MDC) were the lowest in 
the case of P. verrucosum among all other tested.   
Minimum demelanizing concentrations are very close to the minimum inhibitory 
concentrations but slightly higher, which is marked on Figure 2 with arrows. 
Morphological changes and demelanization of microfungi is presented on Figure 3. 
Changes in both Aspergillus species are obvious (Figure 3A and 3C) and include 
depigmentation, morphological changes of conidiophores and small number of heads and 
nude vesicles, in comparison with untreated culture (Figure 3B and 3D). The 
demelanization and reduction of conidia numbers of Penicillium verrucosum and fialides 
without conidia is in contrast with the control mycelium, which has typical brush-like 
clusters and numerous free conidia. All of these were recorded under light microscope 
(Figure 3E and 3F).  
 
Discussion 
C. atramentaria methanolic extract showed antibacterial and antifungal activities against 
all the tested microorganisms. Osuji et al.20 also reported a good antibacterial activity of 
C. atramentaria methanolic extract (expressed in halos of inhibition zone), especially 
against gram-negative bacteria. Nevertheless, all the compounds exhibited very high 
antibacterial activity, much higher than C. atramentaria methanolic extract and, in most 
of the cases, higher than the two standards.  
The antimicrobial activity of CoA was previously reported by Alves et al.14 against some 
of the herein tested bacteria such as E. coli and L. monocytogenes, but with lower effects, 
probably due to the different methodology used for the screening. 
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For the glucuronide derivative of p-coumaric acid (CoAGP), the antibacterial activity 
decreased or was maintained in comparison with the activity of its parent compound 
(CoA). Nevertheless, both compounds showed higher activity than the extract and, in 
some case, even higher than the standards. This is in agreement with the results obtained 
by Heleno et al.5 that described a decrease or maintenance of antibacterial activity of 
protected glucuronide derivatives of p-hydroxybenzoic and cinnamic acids. Regarding 
antifungal activity, CoAGP gave higher effects than its parental phenolic acid; therefore, 
the inclusion of acetyl groups in the molecule increased the activity of CoA, which is also 
in agreement with the reported activity of protected glucuronide derivatives of p-
hydroxybenzoic and cinnamic acids.5  
Methylated derivatives of p-coumaric acid (CoAM1, CoAM2 and CoAM3) revealed 
higher antimicrobial activity than the parental compound, than the extract and even than 
the standards used. In most of the cases the antimicrobial activity significantly increased 
when compared to the activity of the parental compound CoA due to the inclusion of 
methyl groups in its structure. The opposite was observed for HA and CA that presented 
higher antimicrobial activity than the correspondent methylated derivatives (HAM1, 
HAM2 and HAM3, and CAM, respectively). The inclusion of methyl groups in the 
parental acids did not increase the antimicrobial activity, despite the good results obtained 
comparing with the extract and with standards.  
It should be also highlighted that all the compounds showed much better antifungal than 
antibacterial activity 
The colored conidiophores of some Aspergillus and Penicillium species contains 
pigments belonging to the group of melanins: a green colored chromoprotein and a black 
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insoluble pigment.21 Melanin production by fungi contributes to the virulence of 
pathogens of humans as well as those of food crops.22 It was shown that this pigment has 
an important role in the protection of the fungus against immune effector cells; it is able 
to scavenge reactive oxygen species generated by alveolar macrophages and neutrophils 
of the host.23 Because melanin is an important factor in fungal virulence, the 
demelanizing activity of C. atramentaria extract and individual compounds was 
investigated in eight microfungi, the same used for antifungal activity. The results were 
expressed as minimum demelanizing concentrations (MDC), which were defined as 
sublethal and subinhibitory concentration necessary to provoke demelanization in fungus 
during 72 h. Previous studies of demelanization activities of some mushroom extracts 
(Morchella esculenta and Ganoderma lucidum) showed very strong effect on few 
microfungi.4,5 The organic acid derivatives exhibited very strong antifungal activity, but 
also demelanizing effect at very low concentrations on three microfungi: Aspergillus 
niger, A. fumigatus and Penicillium verrucosum var. cyclopium.  
 
Conclusions 
The inclusion of methyl groups in the parental compounds strongly increased the 
antimicrobial activity of CoA, while the inclusion of acetyl groups increased the 
antifungal activity but maintained the antibacterial effects. For HA and CA, the inclusion 
of methyl groups did not increase the antimicrobial activity, but increased the 
demelanizing activity of the parental acids. As far as we know, this is the first report on 
the antifungal and demelanizing activity of C. atramentaria methanolic extract as well as 
antibacterial, antifungal and demelanizing activities of p-coumaric acid and its 
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glucuronide and methylated derivatives, and of p-hydroxybenzoic and cinnamic acid 
methylated derivatives. 
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